Continuing Medical Education (CME)
Continuing Medical Education activities at Good Samaritan Hospital have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through Good Samaritan Hospital, Los Angeles.
Good Samaritan Hospital is accredited by the ACCME to sponsor continuing medical education for physicians. It is the policy of Good Samaritan Hospital to ensure fair balance, independence, objectivity and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose to the audience any real or apparent conflicts of interest related to the content of their presentations. Participating physicians should only claim those hours actually spent in each educational activity.
For more information about Continuing Medical Education, email us at cme@goodsam.org or call (213)-483-8810.
To submit a Good Samaritan Hospital CME Program/Activity Proposal click here.
Current CME Offerings:
Retina Update 2008 - Click here to register online
- CONFERENCE DATE: Saturday, March 22, 2008
- LOCATION: Moseley-Salvatori Conference Center; 636 S. Lucas Avenue
- TIME: 7:00A Registration 8:00A-5:00P Course Presentation (lunch will be provided)
- COURSE FEE: FREE
- COURSE DESCRIPTION: This conference is an annual course for ophthalmologists and optometrists offered by Retina Vitreous and Joint-Sponsored by Good Samaritan Hospital. It reviews many of the common and some uncommon vitreoretinal diseases seen in general and subspecialty ophthalmic practices. It also provides new and established information concerning the diagnosis and treatment of these varied vitreoretinal diseases deemed necessary for continuing education for Ophthalmology and Optometry.
- COURSE OBJECTIVES: At the conclusion of this symposium, participants will be able to describe the pathophysiological factors associated with a wide spectrum of vitreoretinal diseases, recognize current options available to manage the above pathology, and discuses the status of research and current recommendations concerning the vitreoretinal pathology in the United States and the world.